These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 19785851)
1. [Bleeding patterns important factor in choosing an IUD]. van Lunsen RH Ned Tijdschr Geneeskd; 2009; 153():A650. PubMed ID: 19785851 [TBL] [Abstract][Full Text] [Related]
2. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. Suvisaari J; Lähteenmäki P Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872 [TBL] [Abstract][Full Text] [Related]
3. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception. Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577 [TBL] [Abstract][Full Text] [Related]
4. [Summary of the practice guideline 'The intrauterine device' from the Dutch College of General Practitioners]. Boukes FS; Kertzman MG; Smeenk RC; Goudswaard AN Ned Tijdschr Geneeskd; 2009; 153():A578. PubMed ID: 19785853 [TBL] [Abstract][Full Text] [Related]
5. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives. Modesto W; Bahamondes MV; Bahamondes L Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309 [TBL] [Abstract][Full Text] [Related]
7. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices. Heinemann K; Reed S; Moehner S; Minh TD Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350 [TBL] [Abstract][Full Text] [Related]
8. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)]. Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443 [TBL] [Abstract][Full Text] [Related]
9. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system. Sturridge F; Guillebaud J Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696 [TBL] [Abstract][Full Text] [Related]
10. Acceptability of intrauterine contraception among women living with human immunodeficiency virus: a randomised clinical trial. Kakaire O; Tumwesigye NM; Byamugisha JK; Gemzell-Danielsson K Eur J Contracept Reprod Health Care; 2016 Jun; 21(3):220-6. PubMed ID: 26895345 [TBL] [Abstract][Full Text] [Related]
11. Extended use of the intrauterine device: a literature review and recommendations for clinical practice. Wu JP; Pickle S Contraception; 2014 Jun; 89(6):495-503. PubMed ID: 24679478 [TBL] [Abstract][Full Text] [Related]
12. Intrauterine devices: an effective alternative to oral hormonal contraception. Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436 [TBL] [Abstract][Full Text] [Related]
20. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis. Kelekci S; Kelekci KH; Yilmaz B Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]